There are currently 17 clinical trials in Pinellas Park, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Radiant Research Inc., DMI Research, DMI Research, Inc. and GSK Investigational Site. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Study to Assess EN3835 in the Treatment of Plantar Fasciitis (PFA)
Recruiting
This study will assess the efficacy, safety, and tolerability of 2 different doses of EN3835 compared to placebo.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/04/2024
Locations: Endo Clinical Site 3, Pinellas Park, Florida
Conditions: Plantar Fasciitis
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)
Recruiting
A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.
Gender:
All
Ages:
50 years and above
Trial Updated:
03/26/2024
Locations: ShORe Investigational Site, Pinellas Park, Florida
Conditions: Neovascular Age-related Macular Degeneration
Fenofibrate for Prevention of DR Worsening
Recruiting
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the dru... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/25/2024
Locations: Southeast Eye Institute, P.A. dba Eye Associates of Pinellas, Pinellas Park, Florida
Conditions: Diabetic Retinopathy
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/01/2023
Locations: Gastro Florida, Pinellas Park, Florida
Conditions: Ulcerative Colitis
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
Recruiting
This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with non alcoholic steatohepatitis (NASH). as well as the safety and tolerability of AXA1125. Subjects will take one of two different doses of AXA1125 or a placebo twice daily, and a liver biopsy will be done at the beginning and end of the 48-week study.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/07/2022
Locations: Theia Clinical Research, LLC, Pinellas Park, Florida
Conditions: Non Alcoholic Steatohepatitis (NASH)